WAC Price

Quote
























the name should be your least concern. The product is a great one. Evzio is a much needed option and Auvi Q may make a return to market. That said, because the company was relying on Auvi Q royalty they now appear to be in a bit of panic mode. To me the churn and burn comp plan isn't limited to just the plan. That is the stated plan with the reps as well. Why work for a company that has that mentality toward its employees? The potential to be tracked everywhere by the mileage reimbursement app is pathetic and will give good people pause. We want to be treated like adults not monitored 24/7. Finally, people talk. They are paying reps almost half of what they used to. That's bs in this industry and word gets around. I saw a poster on here said his buddy was offered 58k?? That's pathetic. Lots of pluses and minuses on this company just do your homework.
 
  • Like
Reactions: Cha-Cha






The company is pathetic. I am surprised they have not been sued. They took a product that was 450.00 and raised it to over 3400.00. They are not being paid on Medicare or Medicade. They are raping commercial insurance. The bubble on this company is about to burst. They are on many people's radar. Management is from device and totally off the mark for this product. I will reiterate this product is great and timely. The company culture is beyond horrific. If you want a job for 6 months and stress that keeps you awake at night take the job. It will destroy your resume!
 


















anonymous said:
Yes sadly. Again I believe it was raised out of necessity due to lost revenue from Auvi Q although the company line is it was initially priced too low
Click to expand...
Does not sound positive. They make a business mistake and the Reps pay.
 






























http://www.politico.com/story/2016/05/drug-prices-addiction-223192

The list price of Kaleo Pharma’s auto-inject version – specifically approved for a people without medical training to use in a life-threatening crisis — soared from $575 to $3,750 per two-dose package in just two years, according to Truven Health Analytics.

Kaleo, on the other hand, says it raised prices of its naloxone product Evzio so it could afford to cover patient copays; insurers say this practice directs patients to pricier branded drugs, while raising everyone’s insurance costs.

“It’s not a solution that addresses the underlying issue, which is the price itself,” said America’s Health Insurance Plans spokeswoman Clare Krusing. “It shows that pharma is willing do to do anything to change the insurance model … so they don’t have to address the underlying price of the medications that they are charging.”

Before the company hiked naloxone prices this year, about two-thirds of Evzio prescriptions were never filled, said Kaleo spokesman Mark Herzog. Since the company started its patient access program in February — which is subsidized by new revenue generated by the price increase — filled prescriptions increased by 83 percent.

The drug in the auto injector is essentially the same as the older generic versions. About all that’s changed is the packaging, which includes voice-activated instructions.

“When I was little I had some dolls that talked,” said Carol Cunningham, medical director for the Ohio Department of Public Safety’s EMS division. “They didn’t cost $400.”

Read more: http://www.politico.com/story/2016/05/drug-prices-addiction-223192#ixzz4FYsSKVVO
Follow us: @politico on Twitter | Politico on Facebook
 






This is old. A new article appeared last week.


Anyway- it's the same blah blah about how Kaleo is ripping off customers . Again, not a sustainable business and I see nuclear things on the horizon. Right Captain?
 






so the doctors that didn't know about the price are getting told by the commercial insurances and directed to other products. Fewer companies are going to cover this thing. Time to go straight and get on real formularies with real contracts folks. I can't work like this
 
























Top Bottom
Back
Quote